PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 4, 2025Journal of Clinical Medicine3 citationsOpen Access

Controversies in Cavernous Malformation Management: A Comprehensive Review of Current Literature

View Full Paper
EMEdoardo MazzucchiLRLaura RausMLMario Lecce

Key Points

  • Cavernous malformations show varied management approaches and treatment strategies, highlighting the need for individualized care.
  • Evidence from recent literature suggests optimal treatment may depend on lesion location and patient-specific factors.
  • The analysis critically reviews the natural history of cavernous malformations, further informing management strategies.
  • Decisions around treatment and the necessity of radiosurgery remain complex, requiring careful consideration of patient circumstances.

Abstract

Intracranial cavernous malformations (CMs) are angiographically occult, slow-flow vascular lesions composed of dilated, mulberry-like capillary clusters lacking intervening brain parenchyma. CMs typically have a low annual hemorrhage risk and are often discovered incidentally. Most patients are asymptomatic or exhibit mild neurological symptoms at the time of diagnosis. Despite decades of investigation, the optimal management of CMs remains controversial. Key clinical dilemmas include identifying which lesions warrant active treatment and when, selecting the best therapeutic approach based on patient age and lesion location (eloquent vs. non-eloquent areas), and determining how to address the hemosiderin rim often found surrounding the malformation. Additional questions involve the role of radiosurgery and appropriate management strategies during pregnancy. This review critically evaluates current literature concerning the natural history and treatment strategies for CMs, emphasizing evidence-based approaches to these unresolved issues. By summarizing and interpreting recent findings, we aim to provide a concise yet comprehensive overview to support clinicians in tailoring patient-specific management plans for this complex neurovascular pathology.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mazzucchi et al. (2025) studied this question.

synapsesocial.com/papers/694023fa2d562116f28fdc4bhttps://doi.org/10.3390/jcm14238614
Ask AI
Helpful
Bookmark
Share
View Full Paper